Exact Mass: 583.2781176000001
Exact Mass Matches: 583.2781176000001
Found 133 metabolites which its exact mass value is equals to given mass value 583.2781176000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dihydrostreptomycin
C21H41N7O12 (583.2813066000001)
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Aminoglycosides KEIO_ID D108; [MS2] KO008925 KEIO_ID D108
Dihydroergotamine
Dihydroergotamine is only found in individuals that have used or taken this drug. It is a 9,10alpha-dihydro derivative of ergotamine. It is used as a vasoconstrictor, specifically for the therapy of migraine disorders. [PubChem]Two theories have been proposed to explain the efficacy of 5-HT1D receptor agonists in migraine: 1) activation of 5-HT1D receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, leads to vasoconstriction, which correlates with the relief of migraine headache and 2) activation of 5-HT1D receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CA - Ergot alkaloids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
tricoumaroyl spermidine
C34H37N3O6 (583.2682222000001)
Annotation level-3
Dihydroegotamine
Dihydrostreptomycin
C21H41N7O12 (583.2813066000001)
tricoumaroyl spermidine
C34H37N3O6 (583.2682222000001)
Tricoumaroyl spermidine belongs to coumaric acids and derivatives class of compounds. Those are aromatic compounds containing Aromatic compounds containing a cinnamic acid moiety (or a derivative thereof) hydroxylated at the C2 (ortho-), C3 (meta-), or C4 (para-) carbon atom of the benzene ring. Tricoumaroyl spermidine is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Tricoumaroyl spermidine can be found in a number of food items such as winter squash, red rice, common pea, and eggplant, which makes tricoumaroyl spermidine a potential biomarker for the consumption of these food products.
dihydroergotamine
Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CA - Ergot alkaloids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D002491 - Central Nervous System Agents > D000700 - Analgesics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.880 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.878 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.874
Tricoumaroyl spermidine (isomer of 2951)
C34H37N3O6 (583.2682222000001)
Annotation level-3
Tricoumaroyl spermidine (isomer of 2952)
C34H37N3O6 (583.2682222000001)
Annotation level-3
Asp Phe Phe Arg
Asp Phe Arg Phe
Asp Arg Phe Phe
Glu His Ile Trp
Glu His Leu Trp
Glu His Trp Ile
Glu His Trp Leu
Glu Ile His Trp
Glu Ile Trp His
Glu Leu His Trp
Glu Leu Trp His
Glu Trp His Ile
Glu Trp His Leu
Glu Trp Ile His
Glu Trp Leu His
Phe Asp Phe Arg
Phe Asp Arg Phe
Phe Phe Asp Arg
Phe Phe Arg Asp
Phe Arg Asp Phe
Phe Arg Phe Asp
His Glu Ile Trp
His Glu Leu Trp
His Glu Trp Ile
His Glu Trp Leu
His His Lys Tyr
His His Tyr Lys
His Ile Glu Trp
His Ile Trp Glu
His Lys His Tyr
His Lys Asn Trp
His Lys Trp Asn
His Lys Tyr His
His Leu Glu Trp
His Leu Trp Glu
His Asn Lys Trp
His Asn Trp Lys
His Trp Glu Ile
His Trp Glu Leu
His Trp Ile Glu
His Trp Lys Asn
His Trp Leu Glu
His Trp Asn Lys
His Tyr His Lys
His Tyr Lys His
Ile Glu His Trp
Ile Glu Trp His
Ile His Glu Trp
Ile His Trp Glu
Ile Trp Glu His
Ile Trp His Glu
Lys His His Tyr
Lys His Asn Trp
Lys His Trp Asn
Lys His Tyr His
Lys Asn His Trp
Lys Asn Trp His
Lys Trp His Asn
Lys Trp Asn His
Lys Tyr His His
Leu Glu His Trp
Leu Glu Trp His
Leu His Glu Trp
Leu His Trp Glu
Leu Trp Glu His
Leu Trp His Glu
Asn His Lys Trp
Asn His Trp Lys
Asn Lys His Trp
Asn Lys Trp His
Asn Trp His Lys
Asn Trp Lys His
Arg Asp Phe Phe
Arg Phe Asp Phe
Arg Phe Phe Asp
Trp Glu His Ile
Trp Glu His Leu
Trp Glu Ile His
Trp Glu Leu His
Trp His Glu Ile
Trp His Glu Leu
Trp His Ile Glu
Trp His Lys Asn
Trp His Leu Glu
Trp His Asn Lys
Trp Ile Glu His
Trp Ile His Glu
Trp Lys His Asn
Trp Lys Asn His
Trp Leu Glu His
Trp Leu His Glu
Trp Asn His Lys
Trp Asn Lys His
Tyr His His Lys
Tyr His Lys His
Tyr Lys His His
(5R,6R)-2,4-Bis-(4-hydroxy-3-methoxybenzyl)-1,5-dibenzyl-3-oxo-6-hydroxy-1,2,4-triazacycloheptane
C34H37N3O6 (583.2682222000001)
2-[(1S,4S)-5-(diaminomethylideneamino)-2-[(2R,5S)-3-[(2S,5R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-3,4,6-trihydroxycyclohexyl]guanidine
C21H41N7O12 (583.2813066000001)
[(5R,6E,8E,10E,13S,14R,15R,16Z)-15-hydroxy-5-methoxy-14,16-dimethyl-3,24-dioxo-22-thia-2,25-diazatricyclo[18.7.1.021,26]octacosa-1(28),6,8,10,16,20,26-heptaen-13-yl] (2R)-2-aminopropanoate
C31H41N3O6S (583.2715926000001)
(6aS,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
N-[(2R,4aS,12aS)-5-methyl-6-oxo-2-[2-oxo-2-(5,6,7,8-tetrahydronaphthalen-2-ylamino)ethyl]-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3-methoxybenzamide
C34H37N3O6 (583.2682222000001)
(6aS,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
ouabain(1-)
An organic anion that is the conjugate base of ouabain resulting from the deprotonation of the furanone moiety; major species at pH 7.3.
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14s,15s,16r,17s)-14-(acetyloxy)-17-benzyl-6,13,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
(2r,4r,7r)-n-[(1s,2s,4r,7s)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),9,12,14-tetraene-4-carboximidic acid
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14s,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,14,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
(2e)-n-{3-[(2e)-n-(4-{[(2e)-1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butyl)-3-(4-hydroxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid
C34H37N3O6 (583.2682222000001)
(1r,2s,3s,5s,6r,8s,10e,12r,13s,14r,15s,16r,17s)-13-(acetyloxy)-17-benzyl-6,14,19-trihydroxy-6,8,14,15-tetramethyl-7-oxo-4-oxa-18-azatetracyclo[10.7.0.0¹,¹⁶.0³,⁵]nonadeca-10,18-dien-2-yl acetate
n-{3-[n-(4-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}butyl)-3-(4-hydroxyphenyl)prop-2-enamido]propyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid
C34H37N3O6 (583.2682222000001)
(1r,2s,3r,4s,4as,8ar)-4-[(1s)-1-(acetyloxy)-2-(5-oxo-2h-furan-3-yl)ethyl]-3-hydroxy-3,4,8,8a-tetramethyl-2-[(2-methylpropanoyl)oxy]-2,4a,5,6-tetrahydro-1h-naphthalen-1-yl pyridine-3-carboxylate
n-[(1s,2s,3r,4s,5s,6r)-3-carbamimidamido-4-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy}-2,5,6-trihydroxycyclohexyl]guanidine
C21H41N7O12 (583.2813066000001)
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
C21H41N7O12 (583.2813066000001)
(2e)-n-[(1e)-7-[(3-aminopropyl)amino]-1-(4-hydroxyphenyl)-3-oxohept-1-en-4-yl]-3-(4-hydroxyphenyl)-n-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]prop-2-enamide
C34H37N3O6 (583.2682222000001)